Six Pharma Firms Under Scanner in Lucknow’s Fake Medicine Crackdown

Authorities in Lucknow have expanded their investigation into the alleged distribution of counterfeit medicines, with six pharmaceutical firms now under scrutiny as part of a wider crackdown on fake drug networks. Officials believe counterfeit medicines are being transported into the city through courier services before being supplied to local markets and nearby districts.

The Food Safety and Drug Administration (FSDA), along with other enforcement agencies, is examining the entire supply chain—from manufacturing and transportation to storage and retail distribution—to identify those allegedly involved in the illegal trade.

Six Firms Under FSDA Scanner

According to officials, six pharmaceutical companies have come under investigation over suspected irregularities in medicine procurement and sales, including transactions allegedly carried out without proper documentation.

Investigators are currently collecting documentary evidence before initiating raids and taking further legal action. The probe gained momentum earlier this week after a joint enforcement operation intercepted a van carrying counterfeit branded medicines, leading to the arrest of one suspect.

Authorities believe the seizure has provided crucial leads into a larger network responsible for moving fake pharmaceutical products into the city.

Probe Expands Beyond Uttar Pradesh

The investigation is no longer limited to Lucknow. Officials suspect the counterfeit medicine network may involve suppliers and dealers operating across multiple states.

To trace the origin of the seized products, the FSDA is coordinating with drug regulatory authorities in other states. Investigators are examining whether counterfeit medicines were relabelled and transported through interstate distribution channels before reaching retailers and consumers.

Laboratory Testing Underway

Officials said identifying counterfeit medicines is often difficult because fake products are designed to closely resemble genuine brands. As a result, enforcement agencies rely on intelligence gathering, laboratory analysis, and technical examination rather than visual inspection alone.

Samples collected during recent raids have been sent for laboratory testing to determine their composition, quality, and compliance with pharmaceutical standards.

Investigators believe counterfeiters primarily target medicines with high consumer demand, including painkillers, antibiotics, fever medications, anti-allergy drugs, and vitamin supplements, making it easier to circulate fake products within the supply chain.

Health Experts Warn of Serious Risks

Medical experts caution that counterfeit medicines may contain incorrect dosages, inadequate active ingredients, or no therapeutic ingredients at all, potentially leaving patients without effective treatment.

Experts also warn that substandard antibiotics can contribute to antimicrobial resistance, while patients with serious medical conditions may face significant health risks if counterfeit medicines replace genuine prescriptions.

Counterfeit Drug Networks Remain a National Challenge

Authorities note that similar counterfeit medicine operations have been uncovered in several parts of India in recent years, highlighting the growing challenge of dismantling organised fake pharmaceutical supply chains.

Representatives from the pharmaceutical trade have urged enforcement agencies to strengthen inspections not only at retail pharmacies but also across manufacturing facilities, wholesale distributors, transport operators, and courier services to disrupt illegal distribution networks more effectively.

Officials have advised consumers to purchase medicines only from licensed pharmacies, request proper invoices, verify packaging and batch numbers, and immediately report any suspected counterfeit products to healthcare professionals or the relevant drug regulatory authorities.

The investigation remains ongoing, and authorities indicated that additional inspections and enforcement action may follow as more evidence is collected.